Rhumbline Advisers Trillium Therapeutics Inc. Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
N/A
-132,421 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
N/A
4,038 Added 3.15%
132,421 $2.33 Million
Q2 2021

Aug 05, 2021
BUY
N/A
128,383 New
128,383 $1.25 Million

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email